Journal Article10.1055/a-2338-3394
Akute Visusminderung nach parabulbärer Triamcinolonacetonid-Injektion
Tamara Bilic,Marie-Alice Amblard,André M. Trouvain,Anna‐Maria Seuthe,Annekatrin Rickmann +4 more
About: This article is published in Klinische Monatsblatter Fur Augenheilkunde. The article was published on 03 Jul 2024.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
References
Central retinal artery occlusion. Retinal survival time.
TL;DR: In this article, the authors investigated the retinal survival time following central retinal artery occlusion (CRAO) by temporarily clamping the CRA at its site of entry into the optic nerve.
454
A review of central retinal artery occlusion: clinical presentation and management
TL;DR: The pathophysiology, epidemiology, and clinical features of CRAO are described, current and future treatments are discussed, including the use of tissue plasminogen activator (tPA) in further clinical trials.
Comparison of the particle sizes of different steroids and the effect of dilution: a review of the relative neurotoxicities of the steroids.
TL;DR: Commercial betamethasone is the recommended preparation if a nonsoluble steroid is preferred, but its routine use awaits further studies on its safety and efficacy.
274
A case report of ophthalmic artery emboli secondary to Calcium Hydroxylapatite filler injection for nose augmentation- long-term outcome.
Eyal Cohen,Yossi Yatziv,Igal Leibovitch,Anat Kesler,Ran Ben Cnaan,Ainat Klein,Dafna Goldenberg,Zohar Habot-Wilner +7 more
TL;DR: Cosmetic injection of calcium hydroxylapatite to the nose bridge can result in arterial emboli to the ophthalmic system with optic nerve, retinal and choroidal involvement causing long term severe visual acuity and visual field impairment.
Central Retinal Artery Occlusion Following Forehead Injection with a Corticosteroid Suspension
TL;DR: Intralesional injection of corticosteroid suspensions into or adjacent to the ocular adnexa is performed by a number of medical specialists including dermatologists to reduce the chance of retinal embolization following entry into the arterial system.
26